Cyclosporin A protects lung function from hyperoxic damage

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 276, Issue 5 20-5, 1999, Pages

  Matthew, E ^a   Pun, R ^a   Simonich, M ^a   Iwamoto, H ^a   Dedman, J ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Capillary congestion; Hyperoxia; Lung compliance; Type I cells; Type II cells; Whole cell recording

Indexed keywords

CYCLOSPORIN A; LUNG SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL SECRETION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG FUNCTION; LUNG INJURY; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032967901     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.276.5.l786     Document Type: Conference Paper

References (41)

1. Arkovitz, M., V. Garcia, C. Szabo, K. McConnell, K. Bove, and J. Wispe. Decreased pulmonary compliance is an early indicator of pulmonary oxygen injury. J. Surg. Res. 67: 193-198, 1997.
2. Avery, M., and J. Mead. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child. 97: 513-523, 1959.
3. Beckman, D., and H. Weiss. Hyperoxia compared to surfactant washout on pulmonary compliance in rats. J. Appl. Physiol. 26: 700-709, 1969.
4. Busing, C. M., L. von Gerstenbergk, P. Dressler, D. Rumm, and K. Wentz. Experimental studies on microcirculation under normobaric hyperoxia using the microspheres method. Exp. Pathol. 19: 146-153, 1981.
5. Chow, R., L. V. Ruden, and E. Neher. Delay in vesicle fusion revealed by electrochemical monitoring of single exocytotic events in adrenal chromaffin cells. Nature 356: 60-63, 1992.
6. Clark, J., T. Weaver, H. Iwamoto, M. Ikegami, A. Jobe, W. Hull, and J. Whitsett. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am. J. Respir. Cell Mol. Biol. 16: 46-52, 1997.
7. Corti, M., A. Brody, and J. Harrison. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14: 309-315, 1996.
8. Crapo, J., B. Barry, H. Foscue, and J. Shelburne. Structural and functional changes in rat lung occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122: 123-145, 1980.
9. Diglio, C., and Y. Kikkawa. Adaptation and behavior of isolated type II cells in culture. Lab. Invest. 37: 622-631, 1977.
10. Dorn, C., W. Rice, and F. Singleton. Calcium mobilization and response recovery following P2-purinoceptor stimulation of rat isolated alveolar type II cells. Br. J. Pharmacol. 97: 163-170, 1989.
11. Ebihara, K., K. Fukunaga, K. Matsumoto, M. Shichiri, and E. Mayamoto. Cyclosporin A stimulation of glucose-induced insulin secretion in MIN6 cells. Endocrinology 137: 5255-5263, 1996.
12. Engstrom, P., B. Holm, and S. Matalon. Surfactant replacement attenuates the increase in alveolar permeability in hyperoxia. J. Appl. Physiol. 67: 688-693, 1989.
13. Fineman, J., J. Wong, and S. Soifer. Hyperoxia and alkalosis produce pulmonary vasodilation independent of endothelium-derived growth factor in newborn lambs. Pediatr. Res. 33: 341-346, 1993.
14. Frank, L., J. Bucher, and R. Roberts. Oxygen toxicity in neonatal and adult animals of various species. J. Appl. Physiol. 45: 699-704, 1978.
15. Ghio, A., P. Francica, and S. Young. Synthetic surfactant scavenges oxidants and protects against hyperoxic lung injury. J. Appl. Physiol. 77: 1217-1223, 1994.
16. Gross, N. Mechanical properties of mouse lung: effects of vacuum degassing on normal hyperoxic and irradiated lungs. J. Appl. Physiol. 51: 391-398, 1981.
17. Hallman, M., T. Merritt, and K. Bry. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin. Pharmacokinet. 26: 215-232, 1994.
18. Ho, S., N. Clipstone, L. Timmermann, J. Northrop, I. Graff, D. Fiorentino, J. Nourse, and G. Crabtree. The mechanisms of action of cyclosporin A and FK506. Clin. Immunol. Immunopathol. 80: S40-S45, 1996.
19. Holm, B., S. Matalon, and J. Finkelstein. Type II pneumocyte changes during hyperoxic lung injury and recovery. J. Appl. Physiol. 65: 2672-2678, 1988.
20. Kapanci, Y., E. Weibel, H. Kaplan, and F. Robinson. Pathogenesis and reversibility of pulmonary lesions of oxygen toxicity in monkeys. III. Ultrastructural and morphometric studies. Lab. Invest. 20: 101-118, 1969.
21. Mason, R., and L. Dobbs. Synthesis of PC and PG by alveolar type II cells in primary culture. J. Biol. Chem. 255: 5101-5107, 1980.
22. Minoo, P., R. King, and J. Coalson. Surfactant proteins and lipids are regulated independently during hypoxia. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L291-L298, 1992.
23. Niu, A., N. Zhou, R. Xie, R. Pun, and S. R. Paul. Computational method to determine capacitance changes in secretory cells (Abstract). FASEB J. 9: A674, 1995.
24. Pigatto, P., N. Mozzanica, M. Polenghi, G. Altomare, and A. Finzi. Cyclosporin A inhibits polymorphonuclear leukocyte chemotaxis in vivo. Transplant. Proc. 20: 91-94, 1988.
25. Renstrom, E., W. Ding, K. Bokvist, and P. Rorsman. Neurotransmitter-induced inhibition of exocytosis insulin-secreting beta cells by activation of calcineurin. Neuron 17: 513-522, 1996.
26. Rice, W., M. Burhans, and J. Wispe. Effect of oxygen exposure on ATP content of rat bronchoalveolar lavage. Pediatr. Res. 25: 396-398, 1989.
27. Rice, W., and F. Singleton. P2Y-purinoceptor regulation of surfactant secretion from rat isolated alveolar type II cells associated with mobilization of intracellular calcium. Br. J. Pharmacol. 91: 833-838, 1987.
28. Rooney, S., L. Gobran, and M. Griese. Signal transduction mechanisms mediating surfactant phospholipid secretion in isolated type II cells. Prog. Respir. Res. 27: 84-91, 1994.
29. Rooney, S., S. Young, and C. Mendelson. Molecular and cellular processing of lung surfactant. FASEB J. 8: 957-967, 1987.
30. Ruhlman, A., and A. Nordheim. Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation. Immunobiology 198: 192-206, 1997.
31. Sandoz Pharmaceutical Company. Cyclosporine. In: Physicians Desk Reference. Montvale, NJ: Medical Economics, 1997, p. 1216.
32. Schreiber, S., and G. Crabtree. The mechanism of action of cyclosporin Aand FK506. Immunol. Today 13: 136-141, 1992.
33. Schumacher, A., and A. Nordheim. Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression. Clin. Investig. 70: 773-779, 1992.
34. Takao, Y., K. Mikawa, K. Nishima, N. Maekawa, and H. Obara. Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiol. Scand. 40: 318-325, 1996.
35. Tokeida, K., H. Iwamoto, C. Bachurski, S. Wert, W. Hull, K. Ikeda, and J. Whitsett. SP-B deficient mice are susceptible to hyperoxic lung injury. Am. J. Respir. Cell Mol. Biol. In press.
36. Voorhout, W. F., T. Veenedaal, H. P. Haagsman, T. E. Weaver, J. A. Whitsett, L. M. G. van Golde, and H. J. Gueze. Intracellular processing of pulmonary surfactant protein B in an endosomal/lysosomal compartment. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L479-L486, 1992.
37. Wang, J., B. Campos, G. Jamieson, M. Kaetzel, and J. Dedman. Functional elimination of calmodulin within the nucleus by targeted expression of an inhibitor peptide. J. Biol. Chem. 270: 30245-30248, 1995.
38. Warburton, D., S. Buckley, L. Cosico, and H. Forman. Sublethal oxidant injury inhibits signal transduction in rat type II pneumocytes. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L217-L220, 1989.
39. Whitsett, J., W. Hull, C. Dion, and J. Lessard. cAMP dependent actin phosphorylation in developing rat lung and type II epithelial cells. Exp. Lung Res. 9: 191-209, 1985.
40. Zhou, Z., S. Misler, and R. Chow. Rapid fluctuations in transmitter release from single vesicles in bovine adrenal chromaffin cells. Biophys. J. 70: 1543-1552, 1996.
41. Zimmerburg, J., M. Curran, and M. Brodwick. Simultaneous electrical and optical measurements show that membrane fusion precedes exocytotic granule swelling during exocytosis of biege mouse mast cells. Proc. Natl. Acad. Sci. USA 84: 1585-1589, 1987.